+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

After our two successful editions, we are glad to announce the 3rd Annual Epigenetics Discovery Congress, which will be taking place on the 12th - 13th of October 2017 in London, UK.

With a tremendous progress in technology to generate and analyze reference epigenomes, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas.  Additionally, novel epigenetic molecules across many target classes for drug discovery, have been the prime focus of the pharmaceutical industry.

To meet and support this pace of the epigenetics research and development field, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.



Post Show Report 2016

Click here to view post show report of the 2nd Annual Epigenetics Discovery Congress.



conference Registration Form

-




 
  

CategoryCost
Academic Delegate£495
Industry Delegate £695
Solution Provider Delegate£995
University & Research Institutes (Early Bird) - 30th June 2017£420
Industry Delegate (Early Bird) - 30th June 2017£575

Agenda

Key Highlights
  • Epigenetics and disease
  • Modulation of the tumor microenvironment
  • bivalent inhibitors of BET bromodomains
  • Chemical Biology Tools for Target Identification and Validation
  • Epigenomics - Impact for Translational Safety Sciences
  • Epigenetic programming and Allergic Disease
  • Epigenetic regulation of biological ageing
  • Effect of environment on lifestyle
  • Transgenerational effects of epigenetics

For more information on the agenda of the conference, you can write to
 us at events@marketsandmarkets.com

Who Should Attend ?

Who should attend?

Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from

Pharmaceutical, Bio-pharmaceutical and Research Institutes working in

·         Epigenetics

·         Developmental Epigenetics

·         Epidemiology

·         Biology

·         Molecular Biology

·         Developmental Biology

·         Biomedical Sciences

·         Biological Sciences

·         Biochemistry

·         Medicinal Chemistry

·         Medicine

·         Genetics and Genomics

·         Developmental Genetics

·         Organic Chemistry

·         Natural Sciences

·         Translational sciences/medicines

Who Should Sponsor

·         Epigenetic Kits

Ø  Bisulfite Conversion Kits

Ø  ChIP-seq Kits

Ø  RNA Sequencing Kits

Ø  Whole Genome Amplification Kits

Ø  5-hmC and 5-mC Analysis Kits

·         Epigenetic Enzymes

Ø  DNA/Protein/RNA modifying Enzymes

·         Epigenetic Instruments

Ø  Genome Sequencing

Ø  Next Generation Sequencing

Ø  Single strand Sequencing

Ø  Peptide arrays

·         Epigenetic Reagents

Ø  Antibodies

Ø  Buffers

Ø  Histones

Ø  Magnetic Beads

Ø  Primers


Advisory Panel

  • Rab Prinjha
    VP, Head of Epinova Epigenetics DPU,
    GlaxoSmithKline, United Kingdom
  • Moshe Szyf
    Department of Pharmacology and Therapeutics,
    Glaxo Smith Kline and James McGill Professor,
    McGill University Medical School, Canada
  • Svetlana Hamm
    Head of Translational Pharmacology,
    4SC AG, Germany
  • Tony Bjourson
    Director of N. Ireland Centre for Stratified Medicine & Professor of Genomics,
    School of Biomedical Sciences,
    Ulster University, Ireland
  • Guro Elisabeth Lind
    Group leader Epigenetics, Department of Molecular Oncology,
    Institute for cancer research, Oslo University
  • Miguel Branco
    Senior Lecturer, Blizard Institute,
    Queen Mary University of London, United Kingdom

SPEAKERS

  • Christopher Schofield

    Head of Organic Chemistry, University of Oxford and fellow of Royal society, UK
  • David M. Wilson

    Senior Director & Head, Oncology Medicinal Chemistry, Astrazeneca, UK
  • James Flanagan

    Senior Lecturer, Cancer epigenetics Unit, Imperial College London, UK
  • Rémi Terranova

    Novartis Institutes for BioMedical Research, Switzerland
  • Miguel Branco

    Senior Lecturer, Blizard Institute, Queen Mary University of London, United Kingdom
  • Paul Hurd

    Senior Lecturer in Epigenetics, Queen Mary University of London, UK
  • Katherine West

    Lecturer in epigenetics, University of Glasgow, UK
  • Colum Walsh

    Professor of Genetics, University of Ulster, UK
  • Paul Shiels

    Professor, Epigenetics, University of Glasgow, UK
  • Gavin Kelsey

    Principal Research Scientist, Epigenetics Programme, The Babraham Institute, UK
  • Petra Hajkova

    Senior Lecturer, MRC Institute of Medical Sciences (LMS), UK
  • Kilian Huber

    Group Leader, Principal Investigator, Group Head / PI, Member of congregation and Supervisor, University of Oxford, UK
  • Jerome Dejardin

    Assistant Professor at INSERM, MSH, France
  • Carlos Buesa

    CEO, Oryzon, Spain
  • Roland Baumgartner

    CSO, 4SC, Germany
  • Maria Toledo

    Assistant Professor, Faculty of Medicine & Health Sciences, The University of Nottingham, United Kingdom
  • Jesse Smith

    Vice President of Biological Sciences, Epizyme, USA
  • Rab Prinjha

    VP, Head of Epinova Epigenetics DPU, GlaxoSmithKline, UK
  • Brian Huntly

    Professor of Leukaemia Stem Cell Biology, University of Cambridge, UK
  • Jelena Mann

    Reader in Epigenetics, Newcastle University, UK
  • Jonathan Turner

    Principal Investigator, Deputy Head of Unit, Luxembourg Institute of Health, Luxembourg
  • Karen Lillycrop

    Senior Lecturer, Biomedical Sciences, University of Southampton, United Kingdom
  • John Holloway

    Associate Dean (Research), Professor of Allergy and Respiratory Genetics Faculty of Medicine University of Southampton, United kingdom
  • Guro Lind

    Professor, Dept. of Molecular oncology, University of Oslo, Norway
  • Paola Arimondo

    DR CNRS ETaC, France
  • Joëlle Rüegg

    Senior Researcher, Swetox & Dept. of Clinical Neuroscience, Karolinska Institutet, Sweden
  • Susan Clark

    Head of the Genome and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia
  • Gabriella Ficz

    Senior Lecturer, Barts Cancer Institute, Queens Mary University of
    

SPONSORS

Sponsors/Exhibitors

 



 

Diagenode

Diagenode

Diagenode is a global provider of complete solutions and services for epigenetics research, based in Liege, Belgium and NJ, USA. We offer innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality, validated antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. Our latest innovations include a low input RNA-seq kit, CRISPR/Cas 9 antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services.


Chromatrap 

Chromatrap is here to shake up the world of chromatin immunoprecipitation by offering researchers a new way of performing ChIP, effortlessly. By eliminating the use of convention beads, its revolutionary solid state system offers a more faster, easier and more sensitive method of performing ChIP. Our team continues to improve and innovate the technology and its protocols to ensure that researchers get the results they want, allowing them to focus on the bigger questions in epigenetics research.


MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 

Exhibiting

All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.


Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

 For sponsorship opportunities please contact us at events@marketsandmarkets.com

Posters

All Poster presentations will take place in breaks and alongside the breakout sessions of the congress.  All the presentation will be displayed in a dedicated area along with accepted posters from both industry & vendor delegates.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:

Email: events@marketsandmarkets.com

Posters Submission Form

 
  

SUPPORTING ASSOCIATIONS

Cancer Epigeneitcs SocietyCancer Epigenetics Society
The
Cancer Epigenetics Society is the first and largest society solely dedicated to cancer epigenetics. The Cancer Epigenetics Society promotes cancer epigenetics research and supports cancer patients worldwide by working on several fronts: the society publishes research articles on the basic, translational, preclinical, and clinical aspects of cancer epigenetics, provides scientists with several cancer epigenetics databases, produces scientific and educational videos, reports daily news that can help better manage or even prevent cancer, and provides access to cancer patient blogs, books, and advocacy and support groups. The Cancer Epigenetics Society is the official publisher of the journals Cancer Epigenetics and Clinical Cancer Epigenetics and awards annual prizes to the best research published in its journals from Society members. The society welcomes applications for membership (currently free) all year round.


The Epigenetics Society Epigenetics Society

The Epigenetics Society is an international scientific society open to all those interested in the epigenetics of any organism and all aspects of epigenetics, including:
> DNA methylation
> DNA hydroxymethylation
> Chromatin modification
> Chromatin higher-order-structure and remodeling
                                                 > Non-coding RNA related to chromatin structure or DNA modification

Membership in the society is free and provides a monthly e-news with “Abstracts in Press,” conference news, job postings and other announcements.


 

UK - PGxUK Pharmacogenetics and Stratified Medicine Network
The Pharmacogenetics and Stratified Medicine Network develops multidisciplinary partnerships between academics, clinicians, industry partners and regulators with patients, to promote the use of stratified medicine in the clinic. 
Through the Network groups of experts from academia, the healthcare sector, regulatory organisations and patient groups have the opportunity to collaborate to analyse patient samples, and interpret their data to stratify patients into the subcategory of their disease, then identify novel drug target sites and develop the much needed new drugs and diagnostics to make stratified medicine a reality in the clinic.


EpigenomicsNetEpigenomicsNet

At EpigenomicsNet (and our sister journal Epigenomics), we provide a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships. Ultimately, we hope this dynamic network will provide a catalyst to accelerate progress and encourage collaboration in this ever-changing field. By joining the network and sharing your news and knowledge, you will be contributing towards the development of this exciting field. But, at a more personal level, this network also gives you the opportunity to connect with your peers and help gain knowledge and connections that may be useful to your work, whether it is research or regulation.


BioPartner UKBioPartner UK

BioPartner UK is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. BioPartner's delegations promote the UK presence at major international biopharma conferences, and companies are assisted with access to government grants and heavily discounted entry fees. Through the BioPartnership Programme, members receive extra benefits and support to effectively trade overseas.

Venue

For more information on the venue of the conference, you can write to us at events@marketsandmarkets.com